| Financial Year |
March 31 2023 |
| Monetary Funds |
905,220,330.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
379,814.39 |
| Accounts Receivable |
328,472,031.31 |
| Advances to Suppliers |
14,026,109.82 |
| Other Receivables |
5,705,787.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
290,001,965.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
237,951.67 |
| Other Current Assets |
10,715,587.63 |
| Total Current Assets |
1,555,173,778.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,109,689.09 |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,068,465.77 |
| Fixed Assetes |
933,014,488.99 |
| Under-construction Projects |
49,962,578.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
144,810,578.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
22,221,221.89 |
| Deferred Income Tax Assets |
36,429,380.04 |
| Other Non-Current Assets |
66,040,953.68 |
| Sub-Total of Non-Current Assets |
1,262,878,888.45 |
| Total Assets |
2,818,052,667.11 |
| Short-Term Loans |
680,825,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
197,889,748.53 |
| Accounts Payable |
176,797,754.40 |
| Accounts Received In Advance |
13,647,451.13 |
| Employee Compensation Payable |
49,658,630.07 |
| Taxes Payable |
43,770,713.55 |
| Interest Payable |
581,494.87 |
| Dividend Payable |
-- |
| Other payables |
17,846,107.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,476,720.53 |
| Other Current Liabilities |
112,864.05 |
| Sub-Total of Current Liabilities |
1,183,664,081.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,000,622.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,393,400.56 |
| Total Liabilities |
1,253,057,481.69 |
| Paid-In Capital(Or Share Stock) |
153,261,920.00 |
| Capital Surplus |
456,498,043.80 |
| Surplus Reserve |
71,106,373.85 |
| LESS:Treasury Stock |
63,063,188.68 |
| Undistributed Profits |
941,191,271.21 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,564,995,185.42 |
| Owner's Equity（Stockholder's Equity） |
1,564,995,185.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,818,052,667.11 |
